VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 559 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2015. The put-call ratio across all filers is 1.96 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,000 | – | 25 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 25 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | – | 25 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 25 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 25 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 25 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | -100.0% | 25 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $1,000 | -50.0% | 25 | -77.9% | 0.00% | 0.0% |
| Q2 2016 | $2,000 | -33.3% | 113 | +352.0% | 0.00% | -50.0% |
| Q4 2015 | $3,000 | -82.4% | 25 | -73.4% | 0.00% | -80.0% |
| Q3 2015 | $17,000 | -46.9% | 94 | -35.6% | 0.01% | -44.4% |
| Q2 2015 | $32,000 | +33.3% | 146 | -14.6% | 0.02% | +20.0% |
| Q4 2014 | $24,000 | +9.1% | 171 | 0.0% | 0.02% | +7.1% |
| Q3 2014 | $22,000 | +10.0% | 171 | +5.6% | 0.01% | +16.7% |
| Q2 2014 | $20,000 | -9.1% | 162 | -4.7% | 0.01% | -14.3% |
| Q1 2014 | $22,000 | – | 170 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,586,582 | $864,160,000 | 32.02% |
| FARLEY CAPITAL L.P. | 341,518 | $44,807,000 | 30.12% |
| LeVasseur Capital Partners LLC | 190,404 | $24,981,000 | 29.94% |
| Ruane, Cunniff & Goldfarb | 34,494,015 | $4,525,615,000 | 23.97% |
| ValueAct Holdings | 18,923,877 | $2,482,813,000 | 16.64% |
| White River Investment Partners, LLC | 90,099 | $11,820,000 | 16.35% |
| Tesuji Partners | 1,368,040 | $179,487,000 | 15.45% |
| Arrow Capital Management, LLC | 197,500 | $25,912,000 | 15.11% |
| Hound Partners | 3,576,998 | $469,302,000 | 14.87% |
| Brahman Capital Corp. | 4,457,153 | $584,778,000 | 12.82% |